92.7K
Downloads
254
Episodes
DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.
Episodes
Thursday Dec 10, 2015
Thursday Dec 10, 2015
Dr. Sameer Thapar (Assistant Professor and Advisor, Drug Safety & Pharmacovigilance, MS Clinical Trial Sciences Program, Biomedical & Health Sciences, Rutgers University) and graduate student Katelin Tonner-Ingram discuss the challenges faced by manufacturers regarding adverse event reporting, a recent shift in who is actually reporting adverse events, and the role of specialty pharmacies in risk management. To learn more about adverse event reporting and risk management, plan to attend the DIA Pharmacovigilance and Risk Management Strategies 2016 conference.
Friday Dec 04, 2015
Friday Dec 04, 2015
Adopting new technology is crucial if the pharmaceutical industry is to measurably improve drug development efficiency. Elisa Cascade (President, Data Solutions, DrugDev) expands upon an article in the October 2015 Global Forum she co-authored with Dr. Claire Sears (DrugDev Director of Investigator Engagement) and discusses in detail the findings from a 2015 survey of DrugDev network investigators to answer the question: With sponsors, regulatory authorities, CROs, and technology companies all working together, are sites, globally, prepared to implement new clinical trial technologies?